William C. Weldon is Chairman and Chief Executive Officer of Johnson & Johnson,[1] just the sixth Chairman in Johnson & Johnson's over one-hundred year history.[2] Weldon has spent his entire working life at J&J. He joined J&J as a sales representative in 1971 and eventually became the head of J&J's Ethicon Endo-Surgery business in 1992. He became the head of J&J's pharmaceutical operations in 1998 and then became J&J's CEO in 2002. As CEO, Weldon engineered some of the largest acquisitions in J&J's history including the purchase of ALZA and Pfizer's consumer-health product line.[3]
This business-related biographical article is a stub. You can help Wikipedia by expanding it.